Akebia Therapeutics, Inc. (AKBA) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Akebia Therapeutics, Inc. (AKBA) Earnings Overview
As of June 22, 2026, Akebia Therapeutics, Inc. (AKBA) reported trailing twelve-month net income of -$21M, reflecting +93.7% year-over-year growth. The company earned $-0.08 per diluted share over the past four quarters, with a net profit margin of -2.3%.
Looking at the long-term picture, AKBA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2025, representing a new all-time high.
Akebia Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FOLD (-$27M net income, -4.3% margin), PTGX (-$115M net income, -282.8% margin), CYCN (-$5M net income, -170.1% margin), AKBA has outperformed on profitability metrics. Compare AKBA vs FOLD →
AKBA Earnings vs Peers
Earnings metrics vs comparable public companies
AKBA Historical Earnings Data (2012–2025)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$5M | +92.3% | $23M | $-0.02 | -2.3% | 9.9% |
| 2024 | -$69M | -33.7% | -$50M | $-0.33 | -43.3% | -31.5% |
| 2023 | -$52M | +44.9% | -$46M | $-0.28 | -26.7% | -23.8% |
| 2022 | -$94M | +66.6% | -$81M | $-0.58 | -32.2% | -27.6% |
| 2021 | -$282M | +26.7% | -$265M | $-1.48 | -133.3% | -125.0% |
| 2020 | -$385M | -37.6% | -$378M | $-2.53 | -130.6% | -128.2% |
| 2019 | -$280M | -62.7% | -$286M | $-2.36 | -83.5% | -85.5% |
| 2018 | -$172M | -123.5% | -$178M | $-1.47 | -82.7% | -85.8% |
| 2017 | -$77M | +43.3% | -$80M | $-1.77 | -43.2% | -44.9% |
| 2016 | -$136M | -123.6% | -$136M | $-3.60 | -8843.5% | -8889.9% |
| 2015 | -$61M | -63.9% | -$62M | $-2.29 | - | - |
| 2014 | -$37M | -181.3% | -$38M | $-2.40 | - | - |
| 2013 | -$13M | -60.7% | -$16M | $-0.68 | - | - |
| 2012 | -$8M | - | -$9M | $-0.81 | - | - |
Download Data
Export AKBA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
AKBA — Frequently Asked Questions
Quick answers to the most common questions about buying AKBA stock.
What is AKBA earnings per share (EPS)?
AKBA trailing twelve-month (TTM) diluted EPS is $-0.08, reflecting +93.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Akebia Therapeutics, Inc.'s net income?
Akebia Therapeutics, Inc. (AKBA) trailing twelve-month net income is $-21M as of 2025. Earnings grew +93.7% year-over-year.
Is AKBA profitable?
AKBA is not currently profitable on a TTM basis, reporting a net loss of $-21M. Net margin is -2.3%. Investors should monitor for a return to profitability.
What is AKBA's earnings growth rate?
AKBA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are AKBA's profit margins?
Akebia Therapeutics, Inc. net profit margin is -2.3%, operating margin is +9.9%, and gross margin is +83.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -16.4%.
Is AKBA growing earnings?
Yes, AKBA earnings are accelerating — EPS growth of +93.7% exceeds the 5-year CAGR of N/A. TTM net income reached $-21M. Earnings momentum is strengthening.
What was AKBA's best earnings year?
Akebia Therapeutics, Inc.'s highest annual net income on record is $-5M, achieved in fiscal year 2025. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were AKBA's earnings last quarter?
AKBA's most recent reported quarter was Q1 2026. Net income was $-9M with diluted EPS of $-0.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.